Prognostic value of estrogen receptor determinations in patients with breast cancer

The estrogen receptor content of human breast cancer specimens is related to the degree of differentiation (grade) of the tumor. In addition, patients with estrogen receptor-positive tumors experience fewer recurrences and remain disease free for a longer priod of time than do patients with receptor-negative tumors. The presence of estrogen receptor is not correlated with lymph node infiltration.